Highd-ose fractionated radiotherapy to 80-Gy for stage I-II medically inoperable non-_mall-cell lung cancer

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 6, 2010, Pages 554-561

  Watkins, J M ^a   Wahlquist, A E ^b   Zauls, A J ^a   Fields, E C ^d   Garrett Mayer, E ^b   Aguero, E G ^a   Silvestri, G A ^c   Sharma, A K ^a  

^a Departments of Radiation Oncology   (United States)

^b Epidemiology ^*  (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Medical inoperability; Non small cell lung cancer; Radiotherapy

Indexed keywords

CARBOPLATIN; ERLOTINIB; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME; CANCER STAGING; DISEASE FREE SURVIVAL; LUNG; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78650665750     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02213.x     Document Type: Article

References (34)

1. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004; 350: 379-92.
2. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60: 615-23.
3. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 2001; 56: 628-38.
4. Gauden S, Ramsay J, Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 1995; 108: 1278-82.
5. Zhao L, West BT, Hayman JA et-al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 68: 103-10.
6. Dosoretz D, Katin M, Blitzer P et-al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992; 24: 3-9.
7. Sibley G, Jamieson T, Marks L et-al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998; 40: 149-54.
8. Coy P, Kennelly G. The role of curative radiotherapy in the treatment of lung cancer. Cancer 1980; 45: 698.
9. Graham PH, Gebski VJ, Langlands AO. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1995; 31: 261-6.
10. Burt PA, Hancock BM, Stout R. Radical radiotherapy for carcinoma of the bronchus: an equal alternative to radical surgery? Clin Oncol 1989; 1: 86-90.
11. Bradley J, Graham MV, Winter K et-al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005; 61: 318-28.
12. Bradley JD, Graham M, Suzanne S et-al. Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC. J Clin Oncol 2005; 23 (Suppl 16): A7063.
13. Newlin HE, Iyengar M, Morris CG et-al. Unresectable squamous cell carcinoma of the lung: an outcomes study. Int J Radiat Oncol Biol Phys 2009; 74: 370-6.
14. Arriagada R, Dunant A, Pignon JP et-al. Long-term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol 2009; 28: 35-42.
15. Strauss GM, Herndon JE, Maddaus MA et-al. Observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group study groups. J Clin Oncol 2008; 26: 5043-51.
16. Butts CA, Ding K, Seymour L et-al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in complete resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol 2009; 28: 29-34.
17. Jeremic B, Shibamoto Y, Acimovic L et-al. Hyperfractionated radiotherapy alone for clinical stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1997; 38: 521-5.
18. Graham MV, Purdy JA, Emami B et-al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45: 323-9.
19. Kwa SL, Lebesque JV, Theuws JC et-al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998; 43: 1-9.
20. Campeau MP, Herschtal A, Wheeler G et-al. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009; 74: 1371-5.
21. Bogart JA, Hodgson L, Seagren SL et-al. Phase I study of accelerated conformal radiotherapy for stage I non-mall-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. J Clin Oncol 2010; 28: 202-6.
22. Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treatmed with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 108-16.
23. Timmerman R, McGarry R, Yiannoutsos C et-al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-9.
24. Chang JY, Balter PA, Dong L et-al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 72: 967-71.
25. Cesaretti JA, Pennathur A, Rosenstein BS et-al. Stereotactic radiosurgery for thoracic malignancies. Ann Thorac Surg 2008; 85: S785-S791.
26. Machtay M, Hsu C, Komaki R et-al. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 2005; 63: 667-71.
27. Patel AH, Ajlouni M, Jin J, Lu M, Ryu S, Movsas B. Is stereotactic body radiotherapy (SBRT) safe for central non-small cell lung cancer (NSCLC) lesions? Int J Radiat Oncol Biol Phys 2008; 77 (Suppl 1): S434-S435.
28. Onishi H, Araki T, Shirato H et-al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma. Cancer 2004; 101: 1623-31.
29. Allen AM, Siracuse KM, Hayman JA, Balter JM. Evaluation of the influence of breathing on the movement and modeling of lung tumors. Int J Radiat Oncol Biol Phys 2004; 58: 1251-7.
30. Shih HA, Jiang SB, Aljarrah KM, Doppke KP, Choi NC. Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2004; 60: 613-22.
31. Willers H, Wurschmidt F, Bunemann H et-al. High-dose radiation therapy alone for inoperable non-small cell lung cancer: experience with prolonged OTTs. Acta Oncol 1998; 37: 101-5.
32. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Parmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicentre trial. Radiother Oncol 1999; 52: 137-48.
33. Sause W, Kolesar P, Taylor S et-al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 2000; 117: 358-64.
34. Curran WJ, Scott CB, Langer CJ et-al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. J Clin Oncol 2003; 22: A2499.